AVEO Oncology

06/03/2026

The AVEO Oncology, an LG Chem company, team recently attended the Oncology Nursing Society (ONS) Congress 2026 in San Antonio, Texas, connecting with oncology nurses and healthcare professionals from across the country. We were grateful to attend during and celebrate all of the nurses and the inimitable role they play in the oncology community.

05/21/2026

This past Monday, members from the AVEO Oncology, an LG Chem company, team participated in the HEADstrong Foundation Invitational Golf Outing in support of Nick’s House Boston. The HEADstrong Foundation’s mission is to provide critical residential, financial, and emotional support for families navigating cancer. AVEO is proud to support this mission that continues to make an incredible impact in the oncology community, and we are grateful for the opportunity to participate in such a meaningful event. ⛳💚

05/12/2026

Our colleague Chris Wixson, Sr. Director, Distribution & GPOs at AVEO Oncology, an LG Chem company, recently participated as a panelist at the AXS26 Summit in the educational session, “Medically Integrated Oncology Care: Evolving Approaches to Patient-Centered Care,” where his insights contributed to a better understanding of how integrated care models are transforming oncology delivery. Chris’s expertise and leadership in distribution strategy and provider engagement continue to play an important role in AVEO’s focus on advancing innovative, patient-centered oncology care.

Come see us at !

We’re diving into Medically Integrated Oncology Care and what it really means to move beyond dispensing and into a fully coordinated, patient-centered care model. Join us as we discuss how integrated pharmacy is driving faster access to therapy, improving adherence, and creating measurable impact across quality, experience, and cost of care.

We're excited to connect, share insights, and continue pushing oncology care forward. See you there!

05/06/2026

National Nurses Week (May 6th - 12th) recognizes nurses whose compassion, expertise and dedication make a profound difference in the lives of patients every day. At AVEO Oncology, an LG Chem company, we are grateful to all nurses, including those who care for individuals impacted by cancer. Thank you for the comfort, guidance and strength you provide to patients and their families.

; American Nurses Association

05/05/2026

AVEO Oncology, an LG Chem company, announced today they will present two abstracts at the upcoming American Society of Clinical Oncology 2026 annual meeting, May 29-June 2, 2026 in Chicago, IL. For full presentation details, read our press release here: https://www.aveooncology.com/aveo-oncology-an-lg-chem-company-announces-two-poster-presentations-at-asco-2026-annual-meeting/ If you are attending , please visit us at booth #26001!

Download PDF BOSTON, May 5, 2026 (PR Newswire) — AVEO Oncology, an LG Chem company (“AVEO”), announced today that two abstracts were accepted for presentation at the upcoming American Society of Clinical Oncology (ASCO) 2026 annual meeting this May 29-June 2, 2026, in Chicago, IL.   Presentat...

05/01/2026

Dr. Arjan Gower Wins Cary Presant Young Investigator Award -
Congratulations to Dr. Arjan Gower, MD, MS of UCLA Health, who was awarded the , sponsored by AVEO Oncology, an LG Chem company, at the 2026 Annual Oncology Leadership & Research Summit in Newport Beach, CA. The award reflects our ongoing commitment to supporting the next generation of scientific leaders and will include a $25,000 grant to advance Dr. Gower's groundbreaking research. Congratulations again to you, Dr. Gower, on this well-deserved recognition for helping shape the future of cancer care! You can read more about the details of his winning project in lung cancer treatment and the award ceremony here: https://oncologytube.com/dr-arjan-gower-cary-presant-young-investigator-award-moasc-2026/

OncologyTube

Dr. Arjan Gower wins the Cary Presant Young Investigator Award at MOASC 2026. The $25,000 AVEO-sponsored grant supports his lung cancer biomarker research.

04/24/2026

AVEO Oncology, an LG Chem company, recently hosted its annual all-company meeting in Nashville, TN, to celebrate our 2025 achievements and build momentum for the year ahead. The meeting was thoughtfully executed and filled with meaningful learning, collaborative workshops, team-building and moments of genuine connection and fun. While in “Music City”, we were able to give back to the local community—a core commitment of our company—by supporting the W.O. Smith Music School, which provides affordable, high-quality music instruction to children from low-income families.

04/21/2026

Today, AVEO Oncology, an LG Chem company, recognizes , a time to stand with patients, caregivers, clinicians, and researchers committed to advancing care for those affected by Acute Myeloid Leukemia (AML). remains an aggressive and complex blood cancer, and many patients, particularly those who are not candidates for intensive chemotherapy, continue to face significant unmet medical needs. We are proud of our collaboration with Blood Cancer United and the Master Clinical Trial, designed to match patients to investigational therapies based on the biological characteristics of their disease, helping to support the development of more personalized treatment approaches.

04/07/2026

THE 2026 KCA CHALLENGE: 81K STRONG
AVEO Oncology, an LG Chem company, is proud to support the Kidney Cancer Association’s “2026 KCA Challenge: 81K Strong.” From March through on June 18th, the is rallying the community to come together and to raise awareness and fund critical research that can make a real difference for patients and families.

Nearly 81,000 people will be diagnosed with kidney cancer this year. Together, we can change that. We are pleased to participate by matching every donated dollar, up to an additional $81,000, to help accelerate progress in kidney cancer research. Every donation, every share and every act of support brings us one step closer to better outcomes and hope for those impacted by kidney cancer.

Join the Challenge and be part of something meaningful:
https://charity.pledgeit.org/2026challenge

04/02/2026

A new episode of the podcast is now live, featuring Michael Bailey, President and CEO of AVEO Oncology, an LG Chem company, in conversation with host Tom Testa. The program shares insights from Mr. Bailey’s leadership journey in the pharmaceutical and biotech industry and through the history of AVEO, ultimately leading to the strategic acquisition that brought AVEO into the LG Chem Life Sciences family. From there, Mr. Bailey discusses AVEO’s oncology focus, pipeline, the company’s strong momentum and growth over the past several years, and where biotech innovation is headed in 2026 and beyond.

📻 Tune in to hear the conversation at https://soundcloud.com/hcnradio/talking-the-walk-michael?utm_source=clipboard&utm_campaign=wtshare&utm_medium=widget&utm_content=https%253A%252F%252Fsoundcloud.com%252Fhcnradio%252Ftalking-the-walk-michael. The show rebroadcasts every weekday at 8:30 AM, 4:30 PM and 12:30 AM ET.